Becton Dickinson and Company

URI: https://gptkb.org/entity/Becton_Dickinson_and_Company
GPTKB entity
Statements (40)
Predicate Object
gptkbp:instanceOf gptkb:public_company
gptkbp:acquiredBy gptkb:CareFusion_(2015)
C. R. Bard (2017)
gptkbp:alsoKnownAs gptkb:BD
gptkbp:annualReport https://investors.bd.com/financials/annual-reports/default.aspx
gptkbp:CEO gptkb:Tom_Polen
gptkbp:countryOfOrigin gptkb:United_States
gptkbp:division gptkb:BD_Interventional
gptkb:BD_Life_Sciences
gptkb:BD_Medical
gptkbp:founded 1897
gptkbp:foundedIn gptkb:New_York_City,_United_States
gptkbp:founder gptkb:Fairleigh_Dickinson
gptkb:Maxwell_Becton
gptkbp:headquartersLocation gptkb:Franklin_Lakes,_New_Jersey,_United_States
https://www.w3.org/2000/01/rdf-schema#label Becton Dickinson and Company
gptkbp:industry medical device
gptkbp:ISIN US0758871091
gptkbp:logo BD logo.svg
gptkbp:marketCap over $70 billion (2023)
gptkbp:memberState over 190
gptkbp:mission Advancing the world of health
gptkbp:netIncome $1.1 billion (2023)
gptkbp:notableProduct needles
biosciences instruments
infusion therapy devices
syringes
gptkbp:numberOfEmployees ~77,000
gptkbp:products gptkb:research_institute
medical devices
diagnostic products
gptkbp:revenue $18.87 billion (2023)
gptkbp:stockExchange gptkb:S&P_500
gptkbp:stockSymbol gptkb:BDX
gptkbp:subsidiary gptkb:C._R._Bard
gptkb:CareFusion
gptkbp:tradedOn gptkb:NYSE:_BDX
gptkbp:website https://www.bd.com
gptkbp:bfsParent gptkb:BDG
gptkbp:bfsLayer 6